Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study Life Science
Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences Life Science
Healthcare Roundup – Roche/Sanofi treatment combo improves survival rates in COVID-19；Dynavax’s Hepatitis B vaccine shows encouraging action in ongoing hemodialysis trial Life Science
Healthcare Roundup – Pfizer taps Dewpoint Therapeutics in $239M dystrophy candidate pact；Gilead’s Kite, Oxford BioTherapeutics ink immuno-oncology pact Life Science
Healthcare Roundup – Moderna’s COVID-19 vaccine authorized in Israel; Moderna and NIH to study the effects of halving the COVID-19 shot Life Science
Healthcare Roundup – EU regulator remains undecided on Moderna’s COVID-19 jab; U.K. rolls out AstraZeneca-Oxford’s COVID-19 vaccine Life Science
Healthcare Roundup – Inovio gains 9% after positive peer-reviewed data for COVID-19 jab, New Wave completes acquisition of aromatherapy retailer Life Science
Healthcare Roundup – Moderna says its vaccine gives immunity against new COVID-19 variant, AstraZeneca’s AZD1222 expected to be effective against new coronavirus strain Life Science
Healthcare Roundup – Pfizer nears deal to provide U.S. with more vaccine doses, Vaccines makers are under pressure amid concerns over new coronavirus strain Life Science
Healthcare Roundup – Vaccine cuts for several U.S. states due to FDA confusion, Pfizer/BioNTech COVID-19 vaccine cleared by EU Life Science
Healthcare Roundup – U.S. FDA gives Moderna’s COVID vaccine emergency use authorization; Pfizer/ BioNTech COVID-19 vaccine rollout reaches long-term care facilities Life Science
Healthcare Roundup – Two healthcare workers suffer allergic reactions to Pfizer/BioNTech COVID-19 shot, United Airlines partners with XpresSpa for COVID-19 testing Life Science
Healthcare Roundup – Most of American public may get vaccine by end of February, Gilead’s Tecartus receives conditional authorization in Europe for blood cancer Life Science
Healthcare Roundup – U.S. prepares for mass inoculations as COVID-19 vaccine rolls out, Bahrain OK’s Chinese COVID-19 vaccine for use Life Science
Healthcare Roundup – Americans could begin getting Pfizer vaccine on Monday, COVID-19 antibody therapy developer AbCellera Bio prices IPO above range at $20 Life Science
